Comparision of IPACK and Periarticular Block With Adductor Block Alone After Total Knee Artroplasty

Overview

105 patients ASA I-III, undergoing total knee arthroplasty under spinal anesthesia, will be randomly assigned into one of three groups, namely group A (n=35), where an adductor canal block, group B (N:35) where an adductor canal block with IPCAK, and group C (n=35) where an adductor canal block with PAI will be performed preoperatively. All patients will receive a standardized multimodal approach. NRS scores will be evaluated in static and dynamic conditions during the first 48 hours postoperatively.

Full Title of Study: “Comparision of IPACK and Periarticular Block With Adductor Block Alone After Total Knee Artroplasty: a Prospective Randomized Trial on Pain and Knee Function After Total Knee Artroplasty”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Investigator)
  • Study Primary Completion Date: August 8, 2021

Detailed Description

Total knee replacement (TKP) is accepted as one of the major orthopedic surgery that most patients suffer from pain in the postoperative period. The primary aim of this research is to compare the analgesic efficacy of infiltration between the popliteal artery and capsule of the knee(IPACK) with the periarticular block when an additional adductor canal block is used. In the literature, adductor canal block(ACB) and sciatic nerve block are used as part of multimodal analgesia for postoperative pain management of patients undergoing TKP. Nevertheless, ACB is found less effective for pain originating from the posterior part of the knee. Sciatic nerve block and periarticular injection(PAI) are commonly used blocks to improve the analgesic effect of ACB. Besides this, ACB is effective for pain originated from the posterior part of the knee. IPACK block is performed under ultrasound guidance and targets the articular branches of tibial, common peroneal, and obturator nerves with sparing lower extremity motor function. Patients scheduled for knee surgery under spinal anesthesia are included fort his study. All groups will be applied 0.03 mg/kg midazolam iv, then spinal anesthesia will be applied to 15 mg 0.5 % heavy bupivacaine. Three groups of 105 patients will be included in the study. Adductor Canal Block (ACB) (Group A ) (n:35): After the patients are given the supine position, under the guidance of the ultrasound linear probe, 10-15cm proximal to the knee joint, under the sartorius muscle, next to the femoral artery. After the saphenous is observed, 0.25% 20 mL of bupivacaine will be given Adductor + İPACK Grup ( group B) (n: 35): Adductor canal 0.25% 20 mL of bupivacaine will be administered. After the knee is flexed, after the convex probe is placed in the popliteal space, 20 ml of 0.25% bupivacaine will be injected into the area between the popliteal artery and the femur called IPACK Adductor + PAI ( group C) (n: 35): Adductor canal 0.25% 20 mL of bupivacaine will be administered. Patients will receive 60 ml of local anesthetic cocktail intraoperatively by the surgeon. At the end of the operation to the peri-articular area (posterior capsule, collateral ligament, quadriceps muscle). Cocktail consists of 40 ml 0.25% bupivacaine + 8 ml 8 mg morphine+12 ml saline. Routine multimodal analgesia will be used for postoperative analgesia

Interventions

  • Procedure: block
    • Adductor canal block
  • Procedure: adductor canal block
    • adductor canal block bupivacain
  • Procedure: Adductor Canal Block plus IPACK Block
    • Adductor Canal Block plus IPACK Block using bupivacaine
  • Procedure: adductor Canal Block plus PAI Block
    • Adductor Canal Block plus PAI Block using bupivacaine

Arms, Groups and Cohorts

  • Active Comparator: Group A
    • Adductor canal block
  • Active Comparator: Group B
    • Adductor canal block plus IPACK
  • Active Comparator: Group C
    • Adductor canal block plus PAI

Clinical Trial Outcome Measures

Primary Measures

  • NRS scores
    • Time Frame: 48 hours
    • Numerical Rating Scale (NRS) scores (Range 0-10, 0=no pain, 10=the worse pain ever)

Secondary Measures

  • Opioid consumption
    • Time Frame: 4-6-8-12-24 and 48 hours
    • Analgesic consumption at 4-6-8-12-24 and 48 hours
  • Range of knee motion
    • Time Frame: 48 hours
    • Degrees of flexion
  • Complications
    • Time Frame: 48 hours
    • Complications
  • Patient satisfaction
    • Time Frame: 48 hours
    • Patients asked whether they would choose the same anaesthetic management in a future operation: Yes/No
  • Incidence of adverse events related to nerve block procedures
    • Time Frame: Post-op 24 to 72 hours
    • muscle weakness, systemic toxicity
  • Rate of postoperative nausea and vomiting
    • Time Frame: Post-op 24 to 48 hours
    • nausea, vomiting
  • Patient mobilization
    • Time Frame: 2 days
    • Patient reporting time of first standing to the side of the bed and time up and go test 2 days

Participating in This Clinical Trial

Inclusion Criteria

  • Physical status according to American Society of Anesthesiologists (ASA) I-III – Patients scheduled for total knee arthroplasty Exclusion Criteria:

  • Previous operation on same knee – Hepatic or renal insufficiency – Younger than 18 years old and older than 85 – Patients undergoing general anesthesia – Allergy or intolerance to one of the study medications – BMI > 40 – ASA IV – Chronic gabapentin/pregabalin use (regular use for longer than 3 months) – Chronic opioid use (taking opioids for longer than 3 months, or daily oral morphine equivalent of >5mg/day for one month)

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 85 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Karaman Training and Research Hospital
  • Provider of Information About this Clinical Study
    • Sponsor

References

Kertkiatkachorn W, Kampitak W, Tanavalee A, Ngarmukos S. Adductor Canal Block Combined With iPACK (Interspace Between the Popliteal Artery and the Capsule of the Posterior Knee) Block vs Periarticular Injection for Analgesia After Total Knee Arthroplasty: A Randomized Noninferiority Trial. J Arthroplasty. 2021 Jan;36(1):122-129.e1. doi: 10.1016/j.arth.2020.06.086. Epub 2020 Jul 2.

Kim DH, Beathe JC, Lin Y, YaDeau JT, Maalouf DB, Goytizolo E, Garnett C, Ranawat AS, Su EP, Mayman DJ, Memtsoudis SG. Addition of Infiltration Between the Popliteal Artery and the Capsule of the Posterior Knee and Adductor Canal Block to Periarticular Injection Enhances Postoperative Pain Control in Total Knee Arthroplasty: A Randomized Controlled Trial. Anesth Analg. 2019 Aug;129(2):526-535. doi: 10.1213/ANE.0000000000003794.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.